The p38α MAPK Deletion in Oligodendroglia does not Attenuate Myelination Defects in a Mouse Model of Periventricular Leukomalacia

Seung H. Chung, Sangita Biswas, Jiho Sohn, Peng Jiang, Samaneh Dehghan, Hassan Marzban, Wenbin Deng

Research output: Contribution to journalArticle

Abstract

Periventricular leukomalacia (PVL) is a severe type of white matter damage in premature infants and the most common cause of cerebral palsy. It is generally known to be caused by hypoxia and inflammation. Currently there is no effective treatment available, in part due to that the pathogenesis of the disease has not been well understood. The p38α mitogen-activated protein kinase (MAPK) is the serine/threonine kinase and several in vitro studies demonstrated that p38 MAPK is essential for oligodendroglial differentiation and myelination. Indeed, our nerve/glial antigen 2 (NG2)-specific oligodendroglial p38α MAPK conditional knockout (CKO) mice revealed its complex roles in myelination and remyelination. To identify the specific in vivo roles of oligodendroglial p38α MAPK in PVL, we generated a mouse PVL model by combination of LPS-mediated inflammation and hypoxia–ischemia in NG2-p38α MAPK CKO mice. Our results demonstrate that a selective deletion of p38α MAPK in oligodendrocyte did not attenuate myelination defects in the mouse model of PVL. Myelination phenotype revealed by MBP immunostaining was not significantly affected in the p38α MAPK CKO mice compared to the wildtype after PVL induction. The electron microscopic images demonstrated that the microstructure of myelin structures was not significantly different between the wild-type and p38α MAPK CKO mice. In addition, oligodendrocyte degeneration in the corpus callosum white matter area was unaffected in the p38α MAPK CKO during and after the PVL induction. These data indicate that p38α MAPK in oligodendrocyte has minimal effect on myelination and oligodendrocyte survival in the mouse PVL model.

Original languageEnglish (US)
Pages (from-to)175-181
Number of pages7
JournalNeuroscience
Volume386
DOIs
StatePublished - Aug 21 2018

Fingerprint

Periventricular Leukomalacia
Oligodendroglia
p38 Mitogen-Activated Protein Kinases
Knockout Mice
Neuroglia
Inflammation
Antigens
Corpus Callosum
Protein-Serine-Threonine Kinases
Cerebral Palsy
Myelin Sheath
Premature Infants
Electrons

Keywords

  • myelination
  • oligodendrocyte
  • p38alpha MAPK
  • periventricular leukomalacia

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

The p38α MAPK Deletion in Oligodendroglia does not Attenuate Myelination Defects in a Mouse Model of Periventricular Leukomalacia. / Chung, Seung H.; Biswas, Sangita; Sohn, Jiho; Jiang, Peng; Dehghan, Samaneh; Marzban, Hassan; Deng, Wenbin.

In: Neuroscience, Vol. 386, 21.08.2018, p. 175-181.

Research output: Contribution to journalArticle

Chung, Seung H. ; Biswas, Sangita ; Sohn, Jiho ; Jiang, Peng ; Dehghan, Samaneh ; Marzban, Hassan ; Deng, Wenbin. / The p38α MAPK Deletion in Oligodendroglia does not Attenuate Myelination Defects in a Mouse Model of Periventricular Leukomalacia. In: Neuroscience. 2018 ; Vol. 386. pp. 175-181.
@article{78f7a3433f614ed4b0ba2dd12982a283,
title = "The p38α MAPK Deletion in Oligodendroglia does not Attenuate Myelination Defects in a Mouse Model of Periventricular Leukomalacia",
abstract = "Periventricular leukomalacia (PVL) is a severe type of white matter damage in premature infants and the most common cause of cerebral palsy. It is generally known to be caused by hypoxia and inflammation. Currently there is no effective treatment available, in part due to that the pathogenesis of the disease has not been well understood. The p38α mitogen-activated protein kinase (MAPK) is the serine/threonine kinase and several in vitro studies demonstrated that p38 MAPK is essential for oligodendroglial differentiation and myelination. Indeed, our nerve/glial antigen 2 (NG2)-specific oligodendroglial p38α MAPK conditional knockout (CKO) mice revealed its complex roles in myelination and remyelination. To identify the specific in vivo roles of oligodendroglial p38α MAPK in PVL, we generated a mouse PVL model by combination of LPS-mediated inflammation and hypoxia–ischemia in NG2-p38α MAPK CKO mice. Our results demonstrate that a selective deletion of p38α MAPK in oligodendrocyte did not attenuate myelination defects in the mouse model of PVL. Myelination phenotype revealed by MBP immunostaining was not significantly affected in the p38α MAPK CKO mice compared to the wildtype after PVL induction. The electron microscopic images demonstrated that the microstructure of myelin structures was not significantly different between the wild-type and p38α MAPK CKO mice. In addition, oligodendrocyte degeneration in the corpus callosum white matter area was unaffected in the p38α MAPK CKO during and after the PVL induction. These data indicate that p38α MAPK in oligodendrocyte has minimal effect on myelination and oligodendrocyte survival in the mouse PVL model.",
keywords = "myelination, oligodendrocyte, p38alpha MAPK, periventricular leukomalacia",
author = "Chung, {Seung H.} and Sangita Biswas and Jiho Sohn and Peng Jiang and Samaneh Dehghan and Hassan Marzban and Wenbin Deng",
year = "2018",
month = "8",
day = "21",
doi = "10.1016/j.neuroscience.2018.06.037",
language = "English (US)",
volume = "386",
pages = "175--181",
journal = "Neuroscience",
issn = "0306-4522",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - The p38α MAPK Deletion in Oligodendroglia does not Attenuate Myelination Defects in a Mouse Model of Periventricular Leukomalacia

AU - Chung, Seung H.

AU - Biswas, Sangita

AU - Sohn, Jiho

AU - Jiang, Peng

AU - Dehghan, Samaneh

AU - Marzban, Hassan

AU - Deng, Wenbin

PY - 2018/8/21

Y1 - 2018/8/21

N2 - Periventricular leukomalacia (PVL) is a severe type of white matter damage in premature infants and the most common cause of cerebral palsy. It is generally known to be caused by hypoxia and inflammation. Currently there is no effective treatment available, in part due to that the pathogenesis of the disease has not been well understood. The p38α mitogen-activated protein kinase (MAPK) is the serine/threonine kinase and several in vitro studies demonstrated that p38 MAPK is essential for oligodendroglial differentiation and myelination. Indeed, our nerve/glial antigen 2 (NG2)-specific oligodendroglial p38α MAPK conditional knockout (CKO) mice revealed its complex roles in myelination and remyelination. To identify the specific in vivo roles of oligodendroglial p38α MAPK in PVL, we generated a mouse PVL model by combination of LPS-mediated inflammation and hypoxia–ischemia in NG2-p38α MAPK CKO mice. Our results demonstrate that a selective deletion of p38α MAPK in oligodendrocyte did not attenuate myelination defects in the mouse model of PVL. Myelination phenotype revealed by MBP immunostaining was not significantly affected in the p38α MAPK CKO mice compared to the wildtype after PVL induction. The electron microscopic images demonstrated that the microstructure of myelin structures was not significantly different between the wild-type and p38α MAPK CKO mice. In addition, oligodendrocyte degeneration in the corpus callosum white matter area was unaffected in the p38α MAPK CKO during and after the PVL induction. These data indicate that p38α MAPK in oligodendrocyte has minimal effect on myelination and oligodendrocyte survival in the mouse PVL model.

AB - Periventricular leukomalacia (PVL) is a severe type of white matter damage in premature infants and the most common cause of cerebral palsy. It is generally known to be caused by hypoxia and inflammation. Currently there is no effective treatment available, in part due to that the pathogenesis of the disease has not been well understood. The p38α mitogen-activated protein kinase (MAPK) is the serine/threonine kinase and several in vitro studies demonstrated that p38 MAPK is essential for oligodendroglial differentiation and myelination. Indeed, our nerve/glial antigen 2 (NG2)-specific oligodendroglial p38α MAPK conditional knockout (CKO) mice revealed its complex roles in myelination and remyelination. To identify the specific in vivo roles of oligodendroglial p38α MAPK in PVL, we generated a mouse PVL model by combination of LPS-mediated inflammation and hypoxia–ischemia in NG2-p38α MAPK CKO mice. Our results demonstrate that a selective deletion of p38α MAPK in oligodendrocyte did not attenuate myelination defects in the mouse model of PVL. Myelination phenotype revealed by MBP immunostaining was not significantly affected in the p38α MAPK CKO mice compared to the wildtype after PVL induction. The electron microscopic images demonstrated that the microstructure of myelin structures was not significantly different between the wild-type and p38α MAPK CKO mice. In addition, oligodendrocyte degeneration in the corpus callosum white matter area was unaffected in the p38α MAPK CKO during and after the PVL induction. These data indicate that p38α MAPK in oligodendrocyte has minimal effect on myelination and oligodendrocyte survival in the mouse PVL model.

KW - myelination

KW - oligodendrocyte

KW - p38alpha MAPK

KW - periventricular leukomalacia

UR - http://www.scopus.com/inward/record.url?scp=85049533675&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049533675&partnerID=8YFLogxK

U2 - 10.1016/j.neuroscience.2018.06.037

DO - 10.1016/j.neuroscience.2018.06.037

M3 - Article

C2 - 29966722

AN - SCOPUS:85049533675

VL - 386

SP - 175

EP - 181

JO - Neuroscience

JF - Neuroscience

SN - 0306-4522

ER -